Johnson & Johnson (JNJ)
(Real Time Quote from BATS)
$148.15 USD
-1.41 (-0.94%)
Updated Apr 24, 2024 12:18 PM ET
3-Hold of 5 3
C Value D Growth F Momentum D VGM
Price, Consensus and EPS Surprise
JNJ 148.15 -1.41(-0.94%)
Will JNJ be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for JNJ based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for JNJ
The Zacks Analyst Blog Highlights KB Home, Interactive Brokers Group, Qualcomm and Johnson & Johnson
4 Stocks to Watch on Their Recent Dividend Hikes
JNJ: What are Zacks experts saying now?
Zacks Private Portfolio Services
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Pharma Stock Roundup: JNJ's Q1 Results, LLY, ABBV, RHHBY's Successful Study Data
The Zacks Analyst Blog Highlights NVIDIA, Alphabet, Johnson & Johnson, Broadridge Financial and Textron
Other News for JNJ
Prevent Blindness Declares May as First-ever Inherited Retinal Disease (IRD) Genetic Testing Awareness Month
Neurocrine Biosciences upgraded at Wells Fargo on pipeline
Video: Dow Movers: JNJ, BA
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
Johnson & Johnson Stocks Elliott Wave Technical Analysis